000			02108 a2200613 4500
005			20250516184514.0
264		0	_c20140526
008			201405s 0 0 eng d
022			_a1536-3678
024	7		_a10.1097/MPH.0000000000000003 _2doi
040			_aNLM _beng _cNLM
100	1		_aMorgenstern, Daniel A
245	0	0	_aToxicity and outcome of children and adolescents participating in phase I/II trials of novel anticancer drugs: the Royal Marsden experience. _h[electronic resource]
260			_bJournal of pediatric hematology/oncology _cApr 2014
300			_a218-23 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAntineoplastic Agents _xtoxicity
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aClinical Trials, Phase I as Topic
650	0	4	_aClinical Trials, Phase II as Topic
650	0	4	_aDrug Design
650	0	4	_aDrug Discovery _xmethods
650	0	4	_aDrug-Related Side Effects and Adverse Reactions
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHospitalization _xstatistics & numerical data
650	0	4	_aHumans
650	0	4	_aInfant
650	0	4	_aMale
650	0	4	_aNeoplasms _xdrug therapy
650	0	4	_aPatient Admission _xstatistics & numerical data
650	0	4	_aPatient Dropouts
650	0	4	_aPatient Selection
650	0	4	_aRetrospective Studies
650	0	4	_aTreatment Outcome
650	0	4	_aYoung Adult
700	1		_aHargrave, Darren
700	1		_aMarshall, Lynley V
700	1		_aGatz, Susanne A
700	1		_aBarone, Giuseppe
700	1		_aCrowe, Tracey
700	1		_aPritchard-Jones, Kathy
700	1		_aZacharoulis, Stergios
700	1		_aLancaster, Donna L
700	1		_aVaidya, Sucheta J
700	1		_aChisholm, Julia C
700	1		_aPearson, Andrew D J
700	1		_aMoreno, Lucas
773	0		_tJournal of pediatric hematology/oncology _gvol. 36 _gno. 3 _gp. 218-23
856	4	0	_uhttps://doi.org/10.1097/MPH.0000000000000003 _zAvailable from publisher's website
999			_c23352387 _d23352387